134 related articles for article (PubMed ID: 7919549)
41. Taxol sensitizes human astrocytoma cells to radiation.
Tishler RB; Geard CR; Hall EJ; Schiff PB
Cancer Res; 1992 Jun; 52(12):3495-7. PubMed ID: 1350755
[TBL] [Abstract][Full Text] [Related]
42. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW
Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096
[TBL] [Abstract][Full Text] [Related]
43. In vitro studies of Taxol as a radiation sensitizer in human tumor cells.
Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
J Natl Cancer Inst; 1994 Mar; 86(6):441-6. PubMed ID: 7907149
[TBL] [Abstract][Full Text] [Related]
44. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines.
Liebmann J; Cook JA; Lipschultz C; Teague D; Fisher J; Mitchell JB
Cancer Chemother Pharmacol; 1994; 33(4):331-9. PubMed ID: 7904231
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
Kaufmann SH; Peereboom D; Buckwalter CA; Svingen PA; Grochow LB; Donehower RC; Rowinsky EK
J Natl Cancer Inst; 1996 Jun; 88(11):734-41. PubMed ID: 8637027
[TBL] [Abstract][Full Text] [Related]
46. Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
Teicher BA; Holden SA; Eder JP; Herman TS; Antman KH; Frei E
Semin Oncol; 1990 Feb; 17(1 Suppl 3):18-32. PubMed ID: 2106164
[TBL] [Abstract][Full Text] [Related]
47. Chemosensitivity of human small cell carcinoma of the lung detected by flow cytometric DNA analysis of drug-induced cell cycle perturbations in vitro.
Engelholm SA; Spang-Thomsen M; Vindeløv LL; Brünner NA
Cytometry; 1986 May; 7(3):243-50. PubMed ID: 3011370
[TBL] [Abstract][Full Text] [Related]
48. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
Rhodes T; Twentyman PR
Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
[TBL] [Abstract][Full Text] [Related]
49. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
[TBL] [Abstract][Full Text] [Related]
50. Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro.
Akutsu M; Kano Y; Tsunoda S; Suzuki K; Yazawa Y; Miura Y
Eur J Cancer; 1995 Dec; 31A(13-14):2341-6. PubMed ID: 8652267
[TBL] [Abstract][Full Text] [Related]
51. In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects.
Matthews W; Cook J; Mitchell JB; Perry RR; Evans S; Pass HI
Cancer Res; 1989 Apr; 49(7):1718-21. PubMed ID: 2522346
[TBL] [Abstract][Full Text] [Related]
52. [Etoposide effect on cell cycle kinetics of a human lung cancer cell line].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Inoue S; Kawakami Y; Mizuno S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1237-43. PubMed ID: 6732252
[TBL] [Abstract][Full Text] [Related]
53. [Combined effect of cisplatin and caffeine on murine B16-BL6 melanoma cells].
Yasutake H; Tsuchiya H; Sugihara M; Tomita K; Ueda Y; Tanaka M; Sasaki T
Gan To Kagaku Ryoho; 1989 May; 16(5):2031-8. PubMed ID: 2730093
[TBL] [Abstract][Full Text] [Related]
54. Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.
Adjei AA; Davis JN; Bruzek LM; Erlichman C; Kaufmann SH
Clin Cancer Res; 2001 May; 7(5):1438-45. PubMed ID: 11350915
[TBL] [Abstract][Full Text] [Related]
55. [The combined effect of cisplatin and caffeine on human sarcoma cells in vitro].
Tsuchiya H; Tomita K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3125-30. PubMed ID: 3674898
[TBL] [Abstract][Full Text] [Related]
56. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine.
Rowinsky EK; Citardi MJ; Noe DA; Donehower RC
J Cancer Res Clin Oncol; 1993; 119(12):727-33. PubMed ID: 8104946
[TBL] [Abstract][Full Text] [Related]
57. Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro.
Vanhoefer U; Harstrick A; Wilke H; Schleucher N; Walles H; Schröder J; Seeber S
Eur J Cancer; 1995; 31A(1):92-7. PubMed ID: 7695986
[TBL] [Abstract][Full Text] [Related]
58. In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Mori K; Suzuki K; Adachi KI
Cancer Chemother Pharmacol; 1998; 42(2):91-8. PubMed ID: 9654107
[TBL] [Abstract][Full Text] [Related]
59. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
[TBL] [Abstract][Full Text] [Related]
60. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
Perez EA; Hack FM; Webber LM; Chou TC
Cancer Chemother Pharmacol; 1993; 33(3):245-50. PubMed ID: 8269606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
